School of Medicine


Showing 21-40 of 59 Results

  • Daniel Imler

    Daniel Imler

    Clinical Associate Professor, Emergency Medicine

    Current Research and Scholarly Interests I am interested in understanding the impact of smart, agile clinical pathways to drive behavior change among providers.

  • Fatih Inci

    Fatih Inci

    Affiliate, Rad/Canary Center at Stanford for Cancer Early Detection

    Bio Dr. Fatih Inci is currently working as a Research Scientist at Stanford University School of Medicine, Canary Center at Stanford for Cancer Early Detection. He has been guiding and working with a group of researchers, including postdoctoral fellows, graduate, undergraduate, and high school students, who focus on micro- and nano-technologies for biomedical and bioengineering applications. Dr. Inci received his B.Sc. degree at the Department of Molecular Biology and Genetics in 2007 with magna cum laude honor from Istanbul University (Turkey), and also studied as an Sokrates student at the Department of Biology in University of Groningen (Netherlands) in 2005. He received his Ph.D. degree at the Department of Molecular Biology-Genetics & Biotechnology with summa cum laude honor from Istanbul Technical University (Turkey) in 2013. During his Ph.D. studies, he was also appointed as a visiting scientist at University of New South Wales (Sydney, Australia) and University of Technology Sydney (Australia), as well as working as a research scholar/trainee at Brigham and Women?s Hospital (BWH)-Harvard Medical School, and Harvard-MIT Health Sciences and Technology Division (Boston, MA). Upon the completion of his Ph.D. studies, Dr. Inci worked as a postdoctoral research fellow at BWH-Harvard Medical School (2013-2014) and Stanford University School of Medicine (2014-2015).

    Dr. Inci has published his research work in the most prestigious journals, including Proceedings of the National Academy of Sciences of the United States of America (PNAS), ACS Nano, Nature Scientific Reports, Nature Light: Science & Applications, Small, Lab on a chip, Advanced Science, Biomacromolecules, Advanced Drug Delivery Reviews, ACS Chemical Reviews, Biotechnology Advances, Annual Review of Medicine, Materials Today, Trends in Biotechnology. Besides his research publications, he has contributed to the publication of 7 book chapters (including 3 chapters in press) and 3 editorial/perspective papers. He is also editing 3 scientific books in the world's renowned publishers, i.e., Springer Press and World Scientific Publishing Company. His research findings have been presented in national and international conferences, ranging in geography from Barcelona to Osaka, Sydney to Boston, Rio de Janeiro to San Diego and Phoenix to San Francisco. Moreover, he has secured his research findings, technological developments, and scientific discoveries with 6 U.S. patents. Some of them have already been licensed by companies to produce commercial products in the United States, and distributed throughout the world. One such example is his patent in the field of forensics that has been translated into two viable commercial products (CSI-Q and NGDE) produced in the United States by DxNow, Inc.

    Dr. Inci?s qualified scientific work has been highlighted and recognized by well-renowned national and international organizations as well as government entities, including National Institute of Health, Nature Medicine, Science AAAS, Popular Science, Newsweek, Boston University, Canary Center-Stanford University, Brigham & Women?s Hospital, A*STAR, Center for Integration of Medicine and Innovative Technology (CIMIT), and Epilepsy Foundation. He has also been awarded with various scholarships and grants from European Molecular Biology Organization-European Science Foundation (EMBO-ESF), American Chemical Society, and Turkey Scientific and Technological Research Society (TUBITAK). He is a professional member at the world?s largest and most prestigious scientific societies, including the American Association for the Advancement of Science (AAAS), Royal Society of Chemistry (RSC), American Association for Cancer Research (AACR), and National Postdoctoral Association (NPA).

  • Erik Ingelsson

    Erik Ingelsson

    Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly Interests We are interested in the link between metabolic disturbances, such as obesity and insulin resistance, and the development of cardiovascular disease. Our research is translational and interdisciplinary, combining population-based studies with molecular biology to reach new insights into the pathophysiology of cardiovascular disease and related conditions, identification of new biomarkers for improved risk prediction, and discovery of novel drug targets.

  • Alexander Ioannidis

    Alexander Ioannidis

    Postdoctoral Research Fellow, Biomedical Data Sciences

    Bio Alexander Ioannidis (PhD, MPhil) graduated summa cum laude from Harvard University in Chemistry and Physics and earned an M.Phil in Computational Biology and Diploma in Greek from the University of Cambridge. His Ph.D. from Stanford University was in Computational and Mathematical Engineering, where he teaches machine learning and data science. He also has an M.S. in Mgmt. Sci. and Eng. (Optimization) from Stanford. Prior to Stanford, he worked in superconducting computing logic and quantum computing at Northrop Grumman. As a current research fellow in the Stanford School of Medicine (Department of Biomedical Data Science), his work focuses on applying computational methods to problems in genomics and population genetics.

    ---------------------------------------

    I work on novel algorithm design (particularly ancestry related) for several large-scale genomic studies that aim at understanding genetic causes of disease.

    I also focus on projects at the intersection of history and population genetics, including work with native communities. As the grandson of Cappadocian refugees expelled from their native land, I try to engage with the complex sentiments of displaced indigenous peoples in these projects. Pain over the disruption of community heritage and over dispossession from traditional sites often remains raw. If engagement with descendant communities is lacking, research into our past can often feel like a continuation, even a legitimation, of dispossession. Combined alongside a dialogue with native communities, however, genetics can play a small role in helping to reclaim ancestral stories and dispersed ancestral connections. I hope our work in this area plays a constructive role in that process.

    As written by the poet Rumi in the language of the Cappadocians (Rūm),
    ???? ??? ???????? ???? ?? ?????
    ?Tell me what happened to you, tell me what you have lost.?
    [Rumi; Konya ms 67; translit. ?? ?? ?? ??????, ?? ?? ?? ??????]

  • John P.A. Ioannidis

    John P.A. Ioannidis

    Professor of Medicine (Stanford Prevention Research), of Epidemiology and Population Health and by courtesy, of Statistics and of Biomedical Data Science

    Current Research and Scholarly Interests Meta-research
    Evidence-based medicine
    Clinical and molecular epidemiology
    Human genome epidemiology
    Research design
    Reporting of research
    Empirical evaluation of bias in research
    Randomized trials
    Statistical methods and modeling
    Meta-analysis and large-scale evidence
    Prognosis, predictive, personalized, precision medicine and health
    Sociology of science

  • Eric Ip

    Eric Ip

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests My research interests include the use and abuse of anabolic steroids and other performance enhancing/cognitive enhacing drugs.

  • Wui Ip, MD

    Wui Ip, MD

    Affiliate, Dean's Office Operations - Dean Other

    Bio Wui Ip, MD is a pediatrician and clinical informatics fellow, with interests in applying machine learning and analytics to enhance clinical decision support and improve patient care. He also involves in the implementation of telehealth service at LPCH as well as digital health technology innovation at Stanford.

  • Cynthia Irvine

    Cynthia Irvine

    Associate Dean, Office of Medical Education, School of Medicine - Student Affairs

    Current Role at Stanford Associate Dean, Office of Medical Education (MD Program); Co-Director, Scholarly Concentration in Medical Education

Footer Links:

Stanford Medicine Resources: